Triton

provides nutritional support for normal cellular immune function

Triton-MRL is composed of three mycological products mixed in equal proportions. These three products are: 1 - Ganoderma lucidium (Reishi) - 33% 2 - Cordyceps sinensis - 33% 3 - Lentinula edodes (Shiitake) - 33% MRL Ltd.?s Triton-MRL powder contains both mycelium and primordia (young fruit body) of Ganoderma lucidium, Cordyceps sinensis and Lentinula edodes separately cultivated into biomasses that is grown on a sterilised (autoclaved) substrate. This cultivation process ensures the powder is free from contamination by other fungi and that pesticides and heavy metals are absent. The cultivation system is proprietary, allowing for standardised production of Triton when mixed in equal amounts. The powder biomass is then sealed in plastic containers. The mixture of the three mushrooms is processed under rigorously controlled conditions that are applied to the manufacture of a conventional pharmaceutical. This ensures that each tablet contains 500mg of the standardised combination of Ganoderma lucidium, Cordyceps sinensis and Lentinula edodes.The tablets are film coated to protect them from moisture, thus preserving the quality of the product and ensuring a long shelf life. After passing quality control testing the tablets are released for use. The choice of additives used in manufacture renders these tablets suitable for Kosher or vegetarian use.